期刊文献+

丙戊酸镁对利培酮疗效及血药浓度的影响 被引量:1

Effect of magnesium valproate on risperidone efficacy and serum drug concentration
原文传递
导出
摘要 目的观察小剂量丙戊酸镁对利培酮疗效,不良反应及血药浓度的影响。方法将60例精神分裂症患者随机分为对照组(利培酮组)30例和研究组(利培酮+丙戊酸镁)30例。对照组单纯使用利培酮治疗,限定治疗剂量为4mg;研究组同时联合丙戊酸镁片(500-750mg/d)。分别于治疗前与治疗2周末、治疗4周末采用阳性与阴性症状量表(PANSS)评定疗效。采用不良反应量表(TEss)评定治疗中不良反应。于治疗2周末、4周末测定利培酮血药浓度。结果两组利培酮血药浓度测定结果在治疗2周末、4周末比较差异无显著性(P〉0.05)。PANSS评分结果显示,在治疗2周末,研究组与对照组相比,差异有显著性(P〈O.05),而4周末的差异无显著性(P〉0.05)。两组TESS评分结果比较差异无显著性(P〉0.05)。结论联用小剂量丙戊酸镁不会增加利培酮血药浓度。疗效与血药浓度无明显相关,其不良反应未受影响。 Objective Clinical observation of small dose of magnesium valproate on risperidone efficacy, adverse reactions and the effect of drug concentration in blood plasma. Methods 60 Patients with schizophrenia were ran domly divided into control group (30 cases of risperidone group) and study group (risperidone plus magnesium val proate) in 30 cases. The control group was treated with risperidone, defining therapeutic doses for 4mg; study group at the same time combined with magnesium valproate tablets (500-750mg/d). In treatment 2 weekend, 4 weeks after the treatment using positive and negative symptom scale (PANSS) assessment of efficacy. The adverse reaction scale (TESS) assessment of adverse reactions during treatment. In the treatment of 2 weekend, 4 weekend determi nation of the plasma concentration of risperidone. Results 2 Groups of the plasma concentration of risperidone in treatment of determination results of 2 weekend, the 4 weekend of no significant difference ( P 〈 0.05). The score of PANSS results show: in the treatment of 2 weekend, the study group compared with the control group, the difference was statistically significant ( P 〈0.05), while the 4 weekend of the differences were not statistically sig nificant ( P 〈0.05). 2 groups of TESS score was no significant differences. Conclusion Combined with small dose of valproic acid magnesium does not increase the plasma concentration of risperidone, curative effect and serum con centration was not significantly related to, the adverse reaction of unaffected.
出处 《辽宁医学杂志》 2014年第1期9-10,共2页 Medical Journal of Liaoning
关键词 精神分裂症 丙戊酸镁利培酮血药浓度 schizophrenia mgnesium valproate risperidone blood concentration
  • 相关文献

参考文献4

二级参考文献8

  • 1于欣,侯也之,舒良,王秀玲,李冰,刘卫红,林凯,杨顺才,宋丽华,廖安燕,谢家康,贾宏晓,张继志.利培酮治疗精神分裂症的开放性临床验证[J].中华精神科杂志,1997,30(2):79-82. 被引量:330
  • 2Blin O. A comparative review of new antipsychotics[J]. Can J Psychiatry, 1999,44:235~244. 被引量:1
  • 3John K, Stefan L, Daniel C, et al.The expert consensus guideline series optimizing pharmacologic treatment of psychotic disorders[J]. J Clin Psychiatry,2003,64(suppl 12):1~58. 被引量:1
  • 4Nagasaki T,Ohkubo T,Sugawara K,et al. Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography:application to therapeutic drug monitoring in Japanese patients with schizophrenia[J].J Pharm Biomed Anal,1999,19:595~601. 被引量:1
  • 5P. Karlsson,L. Farde,C. Halldin,G. Sedvall,L. Ynddal,M. Sloth-Nielsen. Oral administration of NNC 756 — a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man[J] 1995,Psychopharmacology(1):1~8 被引量:1
  • 6顾牛范,李华芳,宋立升,侯也之,王秀玲,刘平,舒良,白京生,张艳萍,赵靖平,陈晓刚,陈进,张心保,张磊,李鸣,刘连忠,王铭,黄雄,文启琴,王美娟,王欢,周茹英.利培酮治疗精神分裂症多中心开放性研究[J].上海精神医学,1998,10(3):127-130. 被引量:94
  • 7顾牛范,张广岐,姚芳传,袁勇贵.利培酮的国内临床应用概况[J].中华精神科杂志,2001,34(4):250-252. 被引量:53
  • 8高成阁,陈策,曹亚敏,王兰花,李强,亢万虎,马现仓,田萍.利培酮对精神分裂症的疗效及对记忆和注意功能的影响[J].中国新药与临床杂志,2003,22(2):97-100. 被引量:11

共引文献53

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部